Valuation Alkem Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. Other stock markets 06:02:24 2026-08-12 EDT			5-day change	1st Jan Change
5,470.00 ^INR	-0.73%		-3.40%	-0.64%

08-03	Alkem Laboratories Limited Announces Appointment of Rajpal Singh Rana to Senior Management Position, Effective August 03, 2026	CI
07-23	Alkem Laboratories Limited Announces Resignation of Resignation of Jitendra Singh Huda as Senior Management Personnel, Effective from July 23, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	432,909	406,055	590,890	583,680	633,575	660,896	-	-
Change	-	-6.2%	45.52%	-1.22%	8.55%	4.31%	-	-
Enterprise Value (EV) ¹	433,805	393,853	587,236	578,678	632,481	639,163	625,786	635,129
Change	-	-9.21%	49.1%	-1.46%	9.3%	1.06%	-2.09%	1.49%
P/E	26.3x	41.3x	32.9x	27x	27.5x	28.3x	24.6x	21.4x
PBR	5.01x	4.49x	5.73x	4.87x	4.58x	4.31x	3.79x	3.38x
PEG	-	-1x	0.4x	1.3x	4.37x	19.39x	1.7x	1.4x
Capitalization / Revenue	4.07x	3.5x	4.66x	4.5x	4.31x	4x	3.63x	3.27x
EV / Revenue	4.08x	3.4x	4.64x	4.46x	4.3x	3.87x	3.44x	3.15x
EV / EBITDA	21.1x	24.5x	26.2x	23x	21x	18.8x	16.1x	14.3x
EV / EBIT	24.8x	30.3x	30.2x	26.9x	24.1x	21.6x	18.4x	16.1x
EV / FCF	55.4x	27.1x	33.3x	45.3x	42.8x	35.3x	30.1x	26.7x
FCF Yield	1.81%	3.69%	3%	2.21%	2.33%	2.83%	3.32%	3.74%
Dividend per Share ²	34	25	40	45	53	51.35	56.59	69.96
Rate of return	0.94%	0.74%	0.81%	0.92%	1%	0.93%	1.02%	1.27%
EPS ²	137.6	82.31	150.2	181.1	192.5	195.3	224.3	258.2
Distribution rate	24.7%	30.4%	26.6%	24.8%	27.5%	26.3%	25.2%	27.1%
Net sales ¹	106,342	115,993	126,676	129,645	147,123	165,371	182,166	201,902
EBITDA ¹	20,529	16,094	22,455	25,122	30,052	34,011	38,779	44,465
EBIT ¹	17,490	12,990	19,462	21,550	26,232	29,653	34,085	39,396
Net income ¹	16,456	9,842	17,958	21,655	23,018	23,589	27,377	31,444
Net Debt ¹	896.1	-12,202	-3,654	-5,003	-1,094	-21,733	-35,109	-25,767
Reference price ²	3,620.70	3,396.10	4,942.00	4,881.70	5,299.00	5,527.50	5,527.50	5,527.50
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,565	-	-
Announcement Date	5/13/22	5/19/23	5/29/24	5/29/25	5/28/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.45x	12.59x	25.62x	0.57%	1,083B
JOHNSON & JOHNSON	28.9x	-	-	2.07%	626B
ABBVIE INC.	31.93x	7.43x	15.44x	2.74%	442B
ROCHE HOLDING AG	20.56x	4.87x	12.07x	2.71%	363B
NOVARTIS AG	22.02x	5.7x	14.21x	2.82%	295B
ASTRAZENECA PLC	20.5x	4.23x	12.01x	2.08%	248B
AMGEN INC.	25.99x	6.83x	12.15x	2.43%	224B
NOVO NORDISK A/S	13.93x	4.99x	10.37x	3.65%	210B
GILEAD SCIENCES, INC.	-42.16x	6.03x	34.04x	2.43%	168B
Average	17.35x	6.58x	16.99x	2.39%	406.57B
Weighted average by Cap.	24.65x	8.25x	18.71x	1.96%